Periodic safety reporting schedule
| Active Substances | Trade Name | MAH | Year of registration in Saudi Arabia | International Birth Date (IBD) | PSUR Submission Frequency | Data Lock Point (DLP) | Submission Date |
|---|---|---|---|---|---|---|---|
| Nivolumab | Opdivo | BRISTOL-MYERS SQUIBB | 6 months | ||||
| brinzolamide, brimonidine | Simbrinza | ALCON | annual | ||||
| Canakinumab | Ilaris | NOVARTIS | 3 years | ||||
| BALANCED SALT SOLUTION | EYE STREAM SOLN | ALCON | annual | ||||
| ACYCLOVIR | MEDVIROX 5% CREAM | MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES | 3 years | ||||
| Acyclovir 5% Cream | CIVAR | Pharma International Co | 3 years | ||||
| Aciclovir | Aciclovir | PFIZER | 3 Years | ||||
| Aciclovir | ZOVIRAX | GLAXOSMITHKLINE (GSK) | 3 years | ||||
| Daunorubicin Hydrochloride | Daunorubicin Hydrochloride | PFIZER | 3 Years | ||||
| DASATINIB | sprycel | BRISTOL-MYERS SQUIBB | annual |
